Evidence map›Paper›PMID 36077809›Full record

ArticleCancers2022

A Novel Artificial Intelligence-Based Approach for Quantitative Assessment of Angiogenesis in the Ex Ovo CAM Model.

Lorenz Faihs, Bardia Firouz, Paul Slezak, Cyrill Slezak, Michael Weißensteiner, Thomas Ebner, Nassim Ghaffari Tabrizi-Wizsy, Kurt Schicho, Peter Dungel

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lorenz FaihsDepartment of Oral and Maxillofacial Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Bardia FirouzLudwig Boltzmann Institute for Experimental and Clinical Traumatology, 1200 Vienna, Austria.
Paul SlezakLudwig Boltzmann Institute for Experimental and Clinical Traumatology, 1200 Vienna, Austria.
Cyrill SlezakLudwig Boltzmann Institute for Experimental and Clinical Traumatology, 1200 Vienna, Austria.ORCID 0000-0003-4718-9966
Michael WeißensteinerKML Vision GmbH, 8020 Graz, Austria.
Thomas EbnerKML Vision GmbH, 8020 Graz, Austria.ORCID 0000-0001-9153-366X
Nassim Ghaffari Tabrizi-WizsyOtto Loewi Research Center, Department of Immunology and Pathophysiology, SFL Chicken CAM Lab, Medical University of Graz, 8036 Graz, Austria.
Kurt SchichoDepartment of Oral and Maxillofacial Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Peter DungelLudwig Boltzmann Institute for Experimental and Clinical Traumatology, 1200 Vienna, Austria.

Funding

Austrian Research Promotion Agency FFG 853128
6 · The paper itself

Abstract

Angiogenesis is a highly regulated process. It promotes tissue regeneration and contributes to tumor growth. Existing therapeutic concepts interfere with different steps of angiogenesis. The quantification of the vasculature is of crucial importance for research on angiogenetic effects. The chorioallantoic membrane (CAM) assay is widely used in the study of angiogenesis. Ex ovo cultured chick embryos develop an easily accessible, highly vascularised membrane on the surface. Tumor xenografts can be incubated on this membrane enabling studies on cancer angiogenesis and other major hallmarks. However, there is no commonly accepted gold standard for the quantification of the vasculature of the CAM. We compared four widely used measurement techniques to identify the most appropriate one for the quantification of the vascular network of the CAM. The comparison of the different quantification methods suggested that the CAM assay application on the IKOSA platform is the most suitable image analysis application for the vasculature of the CAM. The new CAM application on the IKOSA platform turned out to be a reliable and feasible tool for practical use in angiogenesis research. This novel image analysis software enables a deeper exploration of various aspects of angiogenesis and might support future research on new anti-angiogenic strategies for cancer treatment.

Indexed as

angiogenesisartificial intelligencechorioallantoic membrane assaycomparison of image analysis methods for angiogenesis

Identifiers

PMID36077809
PMCPMC9454718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.